Literature DB >> 25672660

Endothelial dysfunction is associated with the severity of cerebral small vessel disease.

Tomohisa Nezu1, Naohisa Hosomi1, Shiro Aoki1, Satoshi Kubo1, Mutsuko Araki1, Tomoya Mukai1, Tetsuya Takahashi1, Hirofumi Maruyama1, Yukihito Higashi2, Masayasu Matsumoto1.   

Abstract

The pathogenesis of cerebral small vessel disease, a disease that involves white matter lesions (WMLs) and cerebral microbleeds (CMBs), is thought to be associated with endothelial dysfunction. Flow-mediated dilation (FMD) has been used to measure endothelium-dependent vasodilation. The aim of this study was to investigate the association between endothelial function (as measured by FMD) and cerebral small vessel disease. Patients with a history of cerebrovascular disease and comorbidities were enrolled in this study (n=102; 69 males, 70.1±9.2 years). The patients were divided into two groups according to the severity of WMLs, which were assessed by Fazekas classification; grades 0 to 1 as mild WMLs group and grades 2 to 3 as severe WMLs group. A gradient-echo MRI was performed in 96 patients (94.1%) to evaluate whether CMBs were present. The patients in the severe WMLs group (n=40) were older (P=0.001), more frequently exhibited hypertension (P=0.045) and diabetes mellitus (P=0.026) and possessed lower FMD values (P<0.001) than the patients in the mild WMLs group (n=62). CMBs were observed in 30 patients (31.3%). Using receiver operating characteristic curves, the optimal FMD cutoff values for predicting the presence of severe WMLs and CMBs were 3.9% and 3.7%, respectively. On multivariate logistic analysis, FMD <4.0% (odds ratio 9.50; 95% confidence interval 3.55-28.83) was independently associated with severe WMLs. Additionally, FMD <3.8% (5.82; 2.23-16.50) was also associated with the presence of CMBs. Endothelial dysfunction as evaluated by FMD may be predictive of the severity of cerebral small vessel disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25672660     DOI: 10.1038/hr.2015.4

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  42 in total

1.  Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging.

Authors:  K Meguro; J Hatazawa; T Yamaguchi; M Itoh; T Matsuzawa; S Ono; H Miyazawa; T Hishinuma; K Yanai; Y Sekita
Journal:  Ann Neurol       Date:  1990-09       Impact factor: 10.422

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions.

Authors:  Janja Pretnar-Oblak; Miso Sabovic; Miran Sebestjen; Tomaz Pogacnik; Marjan Zaletel
Journal:  Stroke       Date:  2006-08-24       Impact factor: 7.914

4.  Endothelial function and white matter hyperintensities in older adults with cardiovascular disease.

Authors:  Karin F Hoth; David F Tate; Athena Poppas; Daniel E Forman; John Gunstad; David J Moser; Robert H Paul; Angela L Jefferson; Andreana P Haley; Ronald A Cohen
Journal:  Stroke       Date:  2007-01-04       Impact factor: 7.914

5.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

6.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

7.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

8.  Intima-media thickness of brachial artery, vascular function, and cardiovascular risk factors.

Authors:  Yumiko Iwamoto; Tatsuya Maruhashi; Yuichi Fujii; Naomi Idei; Noritaka Fujimura; Shinsuke Mikami; Masato Kajikawa; Takeshi Matsumoto; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; Ayumu Nakashima; Yukihito Higashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-12       Impact factor: 8.311

Review 9.  Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans.

Authors:  Raj N Kalaria
Journal:  Stroke       Date:  2012-08-09       Impact factor: 7.914

10.  Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke.

Authors:  V Palumbo; J M Boulanger; M D Hill; D Inzitari; A M Buchan
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

View more
  15 in total

Review 1.  Neurovascular and Cognitive Dysfunction in Hypertension.

Authors:  Costantino Iadecola; Rebecca F Gottesman
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

2.  In utero exposure to the Great Chinese Famine and risk of intracerebral hemorrhage in midlife.

Authors:  Yun Li; Yanping Li; M Edip Gurol; Yesong Liu; Peng Yang; Jihong Shi; Sheng Zhuang; Michele R Forman; Shouling Wu; Xiang Gao
Journal:  Neurology       Date:  2020-04-10       Impact factor: 9.910

3.  Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk.

Authors:  Cheng Jin; Guohong Li; Kathryn M Rexrode; Mahmut E Gurol; Xiaodong Yuan; Ying Hui; Chunyu Ruan; Anand Vaidya; Yanxiu Wang; Shouling Wu; Xiang Gao
Journal:  Stroke       Date:  2017-12-11       Impact factor: 7.914

4.  The impact of tetrahydrobiopterin administration on endothelial function before and after smoking cessation in chronic smokers.

Authors:  Beth A Taylor; Amanda L Zaleski; Ellen A Dornelas; Paul D Thompson
Journal:  Hypertens Res       Date:  2015-11-26       Impact factor: 3.872

5.  Endothelial Dysfunction of Patients with Peripheral Arterial Disease Measured by Peripheral Arterial Tonometry.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Yoshinori Inoue
Journal:  Int J Vasc Med       Date:  2016-10-18

6.  Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome.

Authors:  Antonino Tuttolomondo; Alessandra Casuccio; Giovanni Guercio; Carlo Maida; Alessandro Del Cuore; Domenico Di Raimondo; Irene Simonetta; Danilo Di Bona; Rosaria Pecoraro; Vittoriano Della Corte; Eliana Gulotta; Gaspare Gulotta; Antonio Pinto
Journal:  Cardiovasc Diabetol       Date:  2017-01-06       Impact factor: 9.951

7.  Alpha-2-macroglobulin as a Promising Biological Marker of Endothelial Function.

Authors:  Ryo Shimomura; Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Takamichi Sugimoto; Naoto Kinoshita; Mutsuko Araki; Tetsuya Takahashi; Hirofumi Maruyama; Masayasu Matsumoto
Journal:  J Atheroscler Thromb       Date:  2017-11-01       Impact factor: 4.928

8.  Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study.

Authors:  Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Noriyuki Suzuki; Tsukasa Teshima; Hitoshi Sugii; Shinobu Nagahama; Yoshiki Kurose; Hirofumi Maruyama; Masayasu Matsumoto
Journal:  J Atheroscler Thromb       Date:  2017-12-09       Impact factor: 4.928

9.  Protective effects of (6R)-5,6,7,8-tetrahydro-l-biopterin on local ischemia/reperfusion-induced suppression of reactive hyperemia in rat gingiva.

Authors:  Yusaku Tanaka; Toshizo Toyama; Satoko Wada-Takahashi; Haruka Sasaki; Chihiro Miyamoto; Yojiro Maehata; Fumihiko Yoshino; Ayaka Yoshida; Shun-Suke Takahashi; Kiyoko Watanabe; Masaichi-Chang-Il Lee; Kazuo Todoki; Nobushiro Hamada
Journal:  J Clin Biochem Nutr       Date:  2015-12-08       Impact factor: 3.114

10.  Astaxanthin inhibits homocysteine‑induced endothelial cell dysfunction via the regulation of the reactive oxygen species‑dependent VEGF‑VEGFR2‑FAK signaling pathway.

Authors:  Xian-Jun Wang; Da-Chen Tian; Feng-Wen Wang; Meng-Hao Zhang; Cun-Dong Fan; Wang Chen; Mei-Hong Wang; Xiao-Yan Fu; Jin-Kui Ma
Journal:  Mol Med Rep       Date:  2019-04-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.